Trial Details
COMPLETEDBasic Information
| Clinical ID | c2332 |
|---|---|
| Identifier | NCT03662919 |
| Trial Title | One-year Persistence to Treatment of Participants Receiving Flixabi or Imraldi: a French Cohort Study |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Arthritis, Rheumatoid|Spondylitis, Ankylosing|Arthritis, Psoriatic|Crohn's Disease|Colitis, Ulcerative |
| Interventions | DRUG: Infliximab|DRUG: Adalimumab |
Participant Information
| Sponsor | Biogen |
|---|---|
| City | Auvergne-Rhône-Alpes |
| Country/Region | France |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2018-07-02 |
|---|---|
| Primary Completion Date | 2022-06-30 |
| Completion Date | 2022-06-30 |